A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2013.02.092

Cited by (1,005)

Items 801–900 of 1,005

  1. Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
    Stephan von Haehling, Birgit Aßmus, Tarek Bekfani, Elke Dworatzek, Frank Edelmann, Djawid Hashemi, Kristian Hellenkamp, Tibor Kempf, Philipp Raake, Katharina Andrea Schütt et al. · 2024 · Clinical Research in Cardiology
  2. Diastolic dysfunction in hypertension: a comprehensive review of pathophysiology, diagnosis, and treatment
    Camilla Ikast Ottosen, Wilson Nadruz, Riccardo Maria Inciardi, Niklas Dyrby Johansen, Marat Fudim, Tor Biering‐Sørensen · 2024 · European Heart Journal - Cardiovascular Imaging
  3. From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress
    Constantijn Franssen, H. Sophia Chen, Nazha Hamdani, Walter J. Paulus · 2015 · Heart
  4. Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction
    Evandro Tinoco Mesquita, Antônio José Lagoeiro Jorge, Celso Vale Souza, Thais Ribeiro de Andrade · 2017 · Arquivos Brasileiros de Cardiologia
  5. Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment
    Andrew V. Xanthopoulos, Filippos K. Triposkiadis, Randall C. Starling · 2018 · Trends in Cardiovascular Medicine
  6. Endothelial function is disturbed in a hypertensive diabetic animal model of HFpEF: Moderate continuous vs. high intensity interval training
    Zelia Schmederer, Natale P. L. Rolim, Thomas Scott Bowen, Axel Hans-Peter Linke, Ulrik Wisløff, Volker Adams · 2018 · International Journal of Cardiology
  7. Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction
    Heng Zeng, Jian‐Xiong Chen · 2019 · Journal of Cardiovascular Pharmacology
  8. Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?
    Valter Lubrano, Silvana Balzan · 2019 · Molecular and Cellular Biochemistry
  9. Mesenchymal Stem/Stromal Cells and their Extracellular Vesicle Progeny Decrease Injury in Poststenotic Swine Kidney Through Different Mechanisms
    Yu Zhao, Xiangyang Zhu, Lei Zhang, Christopher M. Ferguson, Turun Song, Kai Jiang, Sabena M. Conley, James D. Krier, Hui Tang, Ishran M. Saadiq et al. · 2020 · Stem Cells and Development
  10. Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice
    Han Su, Heng Zeng, Xiaochen He, Shaihong Zhu, Jian‐Xiong Chen · 2020 · Journal of the American Heart Association
  11. Left ventricular dysfunction in heart failure with preserved ejection fraction—molecular mechanisms and impact on right ventricular function
    Frank R. Heinzel, Niklas Hegemann, Felix Hohendanner, Uwe Primeßnig, Jana Grune, Florian Blaschke, Rudolf A. de Boer, Burkert Mathias Pieske, Gabriele G. Schiattarella, Wolfgang Michael Kuebler · 2020 · Cardiovascular Diagnosis and Therapy
  12. Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
    Gloria M. Gager, Georg Gelbenegger, Bernd Jilma, Dirk von Lewinski, Harald Sourij, Ceren Eyileten, Krzysztof Jerzy Filipiak, Marek A Postula, Jolanta Maria Siller-Matula · 2021 · Frontiers in Cardiovascular Medicine
  13. The regulation of cardiac intermediary metabolism by NADPH oxidases
    Adam Nabeebaccus, Christina Maria Reumiller, Jie Shen, Anna Zoccarato, Célio X.C. Santos, Ajay M. Shah · 2022 · Cardiovascular Research
  14. Myocardial reverse remodeling: how far can we rewind?
    Patrícia Gonçalves‐Rodrigues, Adelino Ferreira Leite-Moreira, Inês Falcão‐Pires · 2016 · American Journal of Physiology-Heart and Circulatory Physiology
  15. A Microvascular-Myocardial Diastolic Dysfunctional State and Risk for Mental Stress Ischemia
    Carl J. Pepine, John W. Petersen, C. Noel Bairey Merz · 2014 · JACC. Cardiovascular imaging
  16. A Year in Heart Failure: An Update of Recent Findings
    Lorenzo Stretti, Dauphine Zippo, Andrew J.S. Coats, Markus S. Anker, Stephan von Haehling, Marco Metra, Daniela Tomasoni · 2021 · ESC Heart Failure
  17. Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction
    Chenyu Li, Donglu Qin, Jiarui Hu, Yang Yang, Die Hu, Bilian Yu · 2022 · Frontiers in Immunology
  18. The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure
    Benjamin Werbner, Omid Mohammad Tavakoli‐Rouzbehani, Amir Nima Fatahian, Sihem Boudina · 2023 · The Journal of Cardiovascular Aging
  19. Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy
    Sarah Costantino, Alessandro Mengozzi, Srividya Velagapudi, S A Mohammed, Era Gorica, Alexander T. Akhmedov, Alessia Mongelli, Nicola Riccardo Pugliese, Stefano Masi, Agostino Virdis et al. · 2023 · Cardiovascular Diabetology
  20. Contributions of Inflammation to Cardiometabolic Heart Failure with Preserved Ejection Fraction
    Edward Benjamin Thorp, Mallory E. Filipp · 2024 · Annual Review of Pathology Mechanisms of Disease
  21. High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction
    Yuichi Kimura, Yasuhiro Izumiya, Shinsuke Hanatani, Eiichiro Yamamoto, Hiroaki Kusaka, Takanori Tokitsu, Seiji Takashio, Kenji Sakamoto, Kenichi Tsujita, Tomoko Tanaka et al. · 2014 · Heart and Vessels
  22. Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
    Przemysław Jacek Kotyla · 2018 · International Journal of Molecular Sciences
  23. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach
    Prathap Kanagala, Jayanth Ranjit Arnold, Anvesha Singh, Daniel C. S. Chan, Adrian S. H. Cheng, Jamal Nasir Khan, Gaurav Singh Gulsin, Jing Yang, Lei Zhao, Pankaj Gupta et al. · 2020 · PLoS ONE
  24. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Taher Mandviwala, Sukhdeep S. Basra, Umair Khalid, June K. Pickett, Ryle Przybylowicz, Tina Shah, Vijay Nambi, Salim S. Virani, Anita M Deswal · 2020 · International Journal of Obesity
  25. Pulmonary hypertension in aortic valve stenosis
    Micha Tobias Maeder, Lukas Weber, Hans Rickli · 2020 · Trends in Cardiovascular Medicine
  26. The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure
    Parag Goyal, Lauren Balkan, Joanna Bryan Ringel, Scott L. Hummel, Madeline R. Sterling, Samuel Kim, Pankaj Kumar Arora, Elizabeth Anne Jackson, Todd M. Brown, James M. Shikany et al. · 2021 · Journal of Cardiac Failure
  27. Derivation of an Electronic Frailty Index for Predicting Short-Term Mortality in Heart Failure: A Machine Learning Approach
    Chengsheng Ju, Jiandong Zhou, Sharen Lee, Martin Tan, Tong Liu, George Bazoukis, Kamalan Jeevaratnam, Esther W. Chan, Ian Chi Kei Wong, Li Wei et al. · 2021 · ESC Heart Failure
  28. Diastolic left ventricular dysfunction in ankylosing spondylitis—A systematic review and meta-analysis
    Sjoerd C. Heslinga, C.J.J. van Dongen, Thelma C. Konings, Mike J.L. Peters, Irene Eva van der Horst-Bruinsma, Yvo Michiel Smulders, Michael Twahier Nurmohamed · 2014 · Seminars in Arthritis and Rheumatism
  29. Targeting the vasculature in cardiometabolic disease
    Nabil E. Boutagy, Abhishek K. Singh, William C. Sessa · 2022 · Journal of Clinical Investigation
  30. Medial artery calcification in peripheral artery disease
    Tanner I. Kim, Raul J. Guzman · 2023 · Frontiers in Cardiovascular Medicine
  31. Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics
    Chuang Wei, Zeyu Jiang, Congcong Li, Peifeng Li, Qinrui Fu · 2023 · Advanced Functional Materials
  32. SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?
    Dimitris C. Kounatidis, Natalia G. Vallianou, Angelos A Evangelopoulos, Ioannis Vlahodimitris, Eugenia Grivakou, Evangelia Kotsi, Krystalia Dimitriou, Alexandros Skourtis, Iordanis S. Mourouzis · 2023 · Nutrients
  33. Phosphodiesterase in heart and vessels: from physiology to diseases
    Qin Fu, Ying Wang, Yan Chen, Yang K. Xiang · 2023 · Physiological Reviews
  34. Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
    Hack‐Lyoung Kim, Sang‐Ho Jo · 2024 · Journal of Korean Medical Science
  35. Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies
    Agata Magdalena Bielecka-Dabrowa, Agata Sakowicz, Małgorzata Misztal, Stephan von Haehling, Ali Ahmed, Tadeusz Pietrucha, Jacek Rysz, Maciej Banach · 2016 · International Journal of Cardiology
  36. Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension
    Jeremy Aryeh Mazurek, Benjamin Davies Horne, Wajeeha Saeed, Muhammad Rizwan Sardar, Ronald Zolty · 2017 · Heart Lung and Circulation
  37. Causes and Temporal Patterns of 30‐Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction
    Parag Goyal, Matthew Shane Loop, Ligong Chen, Todd M. Brown, Raegan W. Durant, Monika M. Safford, Emily B. Levitan · 2018 · Journal of the American Heart Association
  38. Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases
    Rachel H. Mackey, Lewis H. Kuller, Larry W. Moreland · 2018 · Rheumatic Disease Clinics of North America
  39. Treating Heart Failure with Preserved Ejection Fraction: Learning from Pulmonary Fibrosis
    Francesca Graziani, Francesco Varone, Filippo Crea, Luca Richeldi · 2018 · European Journal of Heart Failure
  40. Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study
    Andrea Silvestrini, Carmine Bruno, Edoardo Vergani, Angela Venuti, Angela Maria Rita Favuzzi, Francesco Guidi, Nicola Nicolotti, Elisabetta Meucci, Alvaro Mordente, Antonio Mancini · 2019 · PLoS ONE
  41. Distinctive patterns of inflammation across the heart failure syndrome
    Gabriele G. Schiattarella, Vasco Sequeira, Pietro Ameri · 2020 · Heart Failure Reviews
  42. Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
    Edgar E. Nollet, Berend Daan Westenbrink, Rudolf A. de Boer, Diederik W.D. Kuster, Jolanda van der Velden · 2020 · Journal of the American Heart Association
  43. Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg
    Daniela Miranda‐Silva, Tânia Lima, Patrícia Rodrigues, Adelino Ferreira Leite-Moreira, Inês Falcão‐Pires · 2021 · Heart Failure Reviews
  44. Evidence for human diabetic cardiomyopathy
    Raffaele Marfella, Celestino Sardu, Gelsomina Mansueto, Claudio Napoli A, Giuseppe Paolisso · 2021 · Acta Diabetologica
  45. Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction
    Antonella De Angelis, Donato Cappetta, Elena Piegari, Barbara Rinaldi, Loreta Pia Ciuffreda, Grazia Esposito, Fiorella Angelica Valeria Ferraiolo, Alessia Rivellino, Rosa Russo, Maria Donniacuo et al. · 2016 · International Journal of Cardiology
  46. Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia
    Yongkang Tao, Heng Zeng, Guoqiang Zhang, Sean T. Chen, Xue‐Jiao Xie, Xiaochen He, Shuo Wang, Hongyan Wen, Jian‐Xiong Chen · 2017 · International Journal of Cardiology
  47. The Association of Protein Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
    Katherine S. Takvorian, Dongyu Wang, Paul L. Courchesne, Ramachandran Srini Vasan, Emelia J. Benjamin, Susan C. Cheng, Martin G. Larson, Daniel A Levy, Jennifer E. Ho · 2022 · Circulation Heart Failure
  48. Sex matters to the heart: A special issue dedicated to the impact of sex related differences of cardiovascular diseases
    Hester M. den Ruijter, Saskia Haitjema, Folkert Wouter Asselbergs, Gerard Pasterkamp · 2015 · Atherosclerosis
  49. Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction
    Sanjiv Jayendra Shah · 2017 · Journal of Cardiovascular Translational Research
  50. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease
    Marie Mide Michelsen, Adam Peña, Naja Dam Mygind, Jan Willem Bech, Ida Gustafsson, Jens Kastrup, Henrik Steen Hansen, Nis Baun Høst, Peter Riis Hansen, Eva Prescott · 2017 · Echocardiography
  51. NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity
    Marina Sokolova, Ivar Sjaastad, Mieke C. Louwe, Katrine Alfsnes, Jan Magnus Aronsen, Lili Zhang, Solveig Bjærum Haugstad, Bård Andre Bendiksen, Jonas Øgaard, Marte Bliksøen et al. · 2019 · Frontiers in Immunology
  52. Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in Korean adults
    Jee Hee Yoo, Sung Woon Park, Ji Eun Jun, Sang‐Man Jin, Kyu Yeon Hur, Moon‐Kyu Lee, Mira Kang, Gyuri Kim, Jae Hyeon Kim · 2020 · Diabetes/Metabolism Research and Reviews
  53. Sex differences in acute cardiovascular care: a review and needs assessment
    Saraschandra Vallabhajosyula, Dhiran Verghese, Viral K. Desai, Pranathi Rao Sundaragiri, Virginia M. Miller · 2021 · Cardiovascular Research
  54. High-intensity interval training versus progressive high-intensity circuit resistance training on endothelial function and cardiorespiratory fitness in heart failure: A preliminary randomized controlled trial
    Natália Turri da Silva, Amanda Vale-Lira, Kenneth Verboven, João Luíz Quagliotti Durigan, Dominique Hansen, Gerson Cipriano · 2021 · PLoS ONE
  55. Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction
    Abdul‐Quddus Mohammed, Yongqiang Luo, Kaitao Wang, Yang Su, Lu Liu, Guoqing Yin, Wen Zhang, Jiasuer Alifu, Redhwan M. Mareai, Ayman Abdulwahed Saif Mohammed et al. · 2024 · Cardiovascular Diabetology
  56. Impact of Coronary Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
    Domenico D’Amario, Renzo Laborante, Emiliano Bianchini, Giuseppe Ciliberti, Donato Antonio Paglianiti, Mattía Galli, Attilio Restivo, Davide Stolfo, Rocco Vergallo, Giuseppe M.C. Rosano et al. · 2024 · ESC Heart Failure
  57. The impact of obesity on heart failure
    Alexander B. Zhai, Haissam A. Haddad · 2017 · Current Opinion in Cardiology
  58. Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations
    Julio A. Chirinos · 2017 · Journal of Cardiovascular Translational Research
  59. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive—A New Preclinical Model
    Claire L. Curl, Vennetia Ryckerens Danes, James R. Bell, Antonia J. A. Raaijmakers, Wendy T.K. Ip, Chanchal Chandramouli, Tristan W. Harding, Enzo R. Porrello, Jeffrey R. Erickson, Fadi Joseph Charchar et al. · 2018 · Journal of the American Heart Association
  60. Cardiorenal syndrome in heart failure with preserved ejection fraction—an under-recognized clinical entity
    Akanksha Agrawal, Mario Naranjo, Napatt Kanjanahattakij, Janani Rangaswami, Shuchita Gupta · 2019 · Heart Failure Reviews
  61. Cytokines in heart failure
    Adina Elena Stanciu · 2019 · Advances in clinical chemistry
  62. Incidence of, Associations With and Prognostic Impact of Worsening Renal Function in Heart Failure With Different Ejection Fraction Categories
    Ida Haugen Löfman, Karolina Elisabeth Szummer, Marie Evans, Juan Jesús Carrero, Lars H. Lund, Tomas Jernberg · 2019 · The American Journal of Cardiology
  63. Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling
    Arnold Piek, Debby P.Y. Koonen, Elisabeth‐Maria Schouten, Eva L. Lindtstedt, Erik Michaëlsson, Rudolf A. de Boer, Herman H.W. Silljé · 2019 · Scientific Reports
  64. Heart Failure Disease Management: A Systematic Review of Effectiveness in Heart Failure with Preserved Ejection Fraction
    Fotini Kalogirou, Faye Forsyth, Martha Kyriakou, Rhys Mantle, Christi Deaton · 2020 · ESC Heart Failure
  65. Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities
    Giovanni Quarta, Mauro Gori, Annamaria Iorio, Emilia D’Elia, James Moon, Attilio Iacovoni, Simone Burocchi, Erik B. Schelbert, Paolo Brambilla, Sandro Sironi et al. · 2020 · European Journal of Heart Failure
  66. Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study
    Christina M. Eckhardt, Pallavi Balte, R. Graham Barr, Alain Gerald Bertoni, Surya Prakash Bhatt, Michael J. Cuttica, Patricia A. Cassano, Paulo H. M. Chaves, David J. Couper, David R. Jacobs et al. · 2022 · European Heart Journal
  67. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
    Nicolas Girerd, Daniel A Levy, Kévin Duarte, João Pedro Ferreira, Christie Mitchell Ballantyne, Timothy John Collier, Anne Pizard, Jens Björkman, Javed Butler, Andrew L. Clark et al. · 2023 · Circulation Heart Failure
  68. Effect of non‐alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population
    Ju Young Jung, Sung Keun Park, Jae‐Hong Ryoo, Chang‐Mo Oh, Jeonggyu Kang, Jae-Hon Lee, Joong‐Myung Choi · 2016 · Hepatology Research
  69. Exercise training improves cardiac autonomic control, cardiac function, and arrhythmogenesis in rats with preserved-ejection fraction heart failure
    David Cristobal Andrade, Alexis Arce‐Álvarez, Camilo Toledo, Hugo S. Díaz, Claudia M.J. Lucero, Harold D. Schultz, Noah Justin Marcus, Rodrigo Del Río · 2017 · Journal of Applied Physiology
  70. Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
    Bharathi Upadhya, Mark J. Haykowsky, Dalane W. Kitzman · 2018 · Heart Failure Reviews
  71. Prognostic value of sST2 in patients with heart failure with reduced, mid-range and preserved ejection fraction
    Yu Song, Fuhai Li, Yamei Xu, Yuan Liu, Yanyan Wang, Xueting Han, Yuyuan Fan, Juan Cao, Jie Luo, Aijun Sun et al. · 2020 · International Journal of Cardiology
  72. Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model
    Moa Lee, Robert J. Glynn, Sebastian Schneeweiß, Kueiyu Joshua Lin, Elisabetta Patorno, Julie Barberio, Raisa Levin, Thomas Evers, Shirley V. Wang, Rishi J. Desai · 2020 · Clinical Epidemiology
  73. Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
    Danielle L. Kirkman, Natalie J. Bohmke, Hayley Billingsley, Salvatore Carbone · 2020 · Frontiers in Endocrinology
  74. Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
    Станислав Алексеевич Сухих, Светлана Носкова, Svetlana A. Ivanova, Elena Ulrikh, Alexsander Izgaryshev, Olga Babich · 2021 · Molecules
  75. High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
    Bo Bai, Min Cheng, Lingyan Jiang, Jiabin Xu, Haibo Chen, Yun Xu · 2021 · Frontiers in Cardiovascular Medicine
  76. Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
    Zofia Wicik, A Nowak, Joanna Jarosz-Popek, Marta Wolska, Ceren Eyileten, Jolanta Maria Siller-Matula, Dirk von Lewinski, Harald Sourij, Krzysztof Jerzy Filipiak, Marek A Postula · 2022 · Frontiers in Pharmacology
  77. Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directions
    Anne Margje Lisa Naomi van Ommen, Elisa Dal Canto, Maarten Jan Cramer, Frans Hendrik Rutten, N. Charlotte Onland‐Moret, Hester M. den Ruijter · 2022 · BMC Medicine
  78. Atrial Fibrillation Coincides with the Advanced Glycation End Product Nε-(Carboxymethyl)Lysine in the Atrium
    Mark P.V. Begieneman, Liza Rijvers, Bela Kubat, Walter J. Paulus, Alexander B. A. Vonk, Albert C. van Rossum, Casper G. Schalkwijk, Wim Stooker, Hans W.M. Niessen, Paul A.J. Krijnen · 2015 · American Journal Of Pathology
  79. Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid Arthritis
    Sicong Huang, Tianrun A. Cai, Brittany Weber, Zhe He, Kumar P. Dahal, Chuan Hong, Jue Hou, Thany Seyok, Andrew Cagan, Marcelo F. DiCarli et al. · 2021 · Arthritis Care & Research
  80. Cardiac ageing: from hallmarks to therapeutic opportunities
    Margaret H. Hastings, Qiulian Zhou, Chao Wu, Parisa Shabani, Shengyuan Huang, Xuejing Yu, Anand Prakash Singh, James Sawalla Guseh, Haobo Li, Carolin Lerchenmüller et al. · 2024 · Cardiovascular Research
  81. Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction
    Sara Leite, Sara Rodrigues, Marta Tavares-Silva, José Oliveira‐Pinto, Mohamed Habib Alaa, Mahmoud Abdellatif, Dulce Fontoura, Inês Falcão‐Pires, Thierry C. Gillebert, Adelino Ferreira Leite-Moreira et al. · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
  82. Heart failure with preserved ejection fraction in hypertension
    Loon Yee Teo, Laura Lihua Chan, Carolyn S.P. Lam · 2016 · Current Opinion in Cardiology
  83. MiRNA Deregulation in Cardiac Aging and Associated Disorders
    Robin Verjans, Marc van Bilsen, Blanche L. M. Schroen · 2017 · International review of cytology
  84. Heart Rate Response and Functional Capacity in Patients with Chronic Heart Failure with Preserved Ejection Fraction
    Eloy Domínguez, Patricia Palau, Eduardo Núñez, José Ramón, Laura López, Joana Melero Lloret, Alejandro Bellver Navarro, Enrique Santas, F. Javier Chorro, Julio E. Núñez · 2018 · ESC Heart Failure
  85. Effects of Endurance Training on Detrimental Structural, Cellular, and Functional Alterations in Skeletal Muscles of Heart Failure With Preserved Ejection Fraction
    Thomas Scott Bowen, Christian Herz, Natale P. L. Rolim, Anne Marie Ormbostad Berre, Martin Halle, Angela Kricke, Axel Hans-Peter Linke, Gustavo José Justo da Silva, Ulrik Wisløff, Volker Adams · 2018 · Journal of Cardiac Failure
  86. Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis)
    Megan Watson, Zeina Dardari, Sina Kianoush, Michael E. Hall, Andrew Paul DeFilippis, Rachel J. Keith, Emelia J. Benjamin, Carlos J. Rodríguez, Aruni Bhatnagar, João A.C. Lima et al. · 2019 · The American Journal of Cardiology
  87. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes
    Xixiang Tang, Junlin Zhong, Hui Zhang, Yanting Luo, Xing Liu, Long Peng, Yanling Zhang, Xiaoxian Qian, Boxiong Jiang, Jinlai Liu et al. · 2019 · Cardiovascular Diabetology
  88. Diastolic dysfunction is initiated by cardiomyocyte impairment ahead of endothelial dysfunction due to increased oxidative stress and inflammation in an experimental prediabetes model
    Mark T. Waddingham, Takashi Sonobe, Hirotsugu Tsuchimochi, Amanda J. Edgley, Vijayakumar Sukumaran, Yi Ching Chen, Sarabjit S. Hansra, Daryl O. Schwenke, Keiji Umetani, Kohki Aoyama et al. · 2019 · Journal of Molecular and Cellular Cardiology
  89. How Should Physicians Assess Myocardial Contraction?
    Mathew S. Maurer, Milton Packer · 2020 · JACC. Cardiovascular imaging
  90. Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study
    Lisandro Damián Colantonio, Kenneth G. Saag, Jasvinder A. Singh, Ligong Chen, Richard J. Reynolds, Angelo Gaffo, Timothy B. Plante, Jeffrey R. Curtis, S. Louis Bridges, Emily B. Levitan et al. · 2020 · Arthritis Research & Therapy
  91. Biomarker profiling for risk of future heart failure (HFpEF) development
    Chris J Watson, Joe Gallagher, Mark Wilkinson, Adam Russell‐Hallinan, Isaac Tea, Stephanie James, James O’Reilly, Eoin O’Connell, Shuaiwei Zhou, Mark T. Ledwidge et al. · 2021 · Journal of Translational Medicine
  92. Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction
    Sérgio Henrique Rodolpho Ramalho, Mário Santos, Brian Lee Claggett, Kunihiro Matsushita, Dalane W. Kitzman, Laura R. Loehr, Scott David Solomon, Hicham Skali, Amil M. Shah · 2019 · JAMA Network Open
  93. Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction
    Adam Castaño, Sabahat Bokhari, Mathew S. Maurer · 2015 · European Heart Journal
  94. Inflammation in Heart Failure With Preserved Ejection Fraction
    Gomberg-Maitland, Mardi, Shah, Sanijv J., Guazzi, Marco · 2016 · JACC Heart Failure
  95. Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction
    Yong Wang, Juan Zhang, Zhen Wang, Cheng Wang, Dufang Ma · 2022 · Heart Failure Reviews
  96. The Natural History of Atrial Functional Mitral Regurgitation
    Jwan A. Naser, Francisco B. Alexandrino, Tomonari Harada, Héctor I. Michelena, Barry A. Borlaug, Mackram F. Eleid, Grace Lin, Christopher G. Scott, Austin M Kennedy, Patricia A. Pellikka et al. · 2024 · Journal of the American College of Cardiology
  97. Low-Density Neutrophils and Neutrophil Extracellular Traps (NETs) Are New Inflammatory Players in Heart Failure
    Benjamin L. Dumont, Paul‐Eduard Neagoe, Elcha Charles, Louis Robert Villeneuve, Sandro Ninni, Jean‐Claude Tardif, Agnès Räkel, Michel White, Martin G. Sirois · 2024 · Canadian Journal of Cardiology
  98. Interplay between frailty and cardiometabolic disorders: from pathophysiology to clinical implications
    Gaetano Santulli, Giada Sabatelli, Brandon Wang, Marco Savino, Francesca Pia Bruno, Stanislovas S. Jankauskas, Annamaria Massaro, Caterina Peluso, Maria Vicario, Luigi Savino et al. · 2025 · Cardiovascular Diabetology
  99. Cardiometabolic Disease Leading to Heart Failure: Better Fat and Fit Than Lean and Lazy
    Ambarish Pandey, Jarett D. Berry, Carl J. Lavie · 2015 · Current Heart Failure Reports
  100. Angiographic Evaluation of Coronary Microvascular Dysfunction in Patients with Heart Failure and Preserved Ejection Fraction
    Vincenzo Sucato, Salvatore Evola, Giuseppina Novo, Angela Sansone, Angelo Quagliana, Giuseppe Andolina, Pasquale Assennato, Salvatore Novo · 2015 · Microcirculation